One BioMed Singapore, a medical diagnostic company is a spin-off of A*Star’s (Agency for Science, Technology, and Research) IME (Institute of Microelectronics). One BioMed Singapore has developed a POC (point-of-care) diagnostic platform by using two patented technologies- a silicon biophotonics sensor and a chemistry-based nucleic acidic extraction. One BioMed aims to address global health needs. #OneBioMedSingapore #Singapore
(Feed generated with FetchRSS)
from Crypto ICO News on Facebook http://bit.ly/2ZT2zI0
via IFTTT
No comments:
Post a Comment